Showing 441 - 460 results of 677 for search '"Cancer treatment"', query time: 0.08s Refine Results
  1. 441

    Bibliometric analysis of rhein in the treatment of tumors by Lan Jiang, Lan Jiang, Lan Jiang, Qian Huang, Zhongquan Shi, Yi Yang

    Published 2025-02-01
    “…However, a comprehensive bibliometric review of this field has not yet been published.ObjectiveThis study aims to investigate and evaluate the current research trends and directions about the antitumor properties of rhein using bibliometric analysis.MethodsThe literature related to rhein in cancer treatment from 2003 to 2023 was retrieved from the Web of Science Core Collection (WoSCC) database, and the annual number of publications, main authors, major institutions, keyword clustering, and keyword bursts were visually analyzed using CiteSpace 6.3.R1 software. …”
    Get full text
    Article
  2. 442

    Furanocoumarin compounds isolated from Dorstenia foetida potentiate irinotecan anticancer activity against colorectal cancer cells by Pengnam Supusson, Jitkaroon Watcharapa, Srisuphan Roongtiwa, Wongprayoon Pawaris, Rayanil Kanok-On, Charoensuksai Purin

    Published 2024-03-01
    “…In conclusion, our results identified compound 2 as a plant-derived compound exhibiting anticancer properties that can act synergistically with Iri and warranted further research to assess the potential of this synergism for colorectal cancer treatment.…”
    Get full text
    Article
  3. 443

    The role of diet and physical activity in PCOS - A Quick Review by Natalia Pawelec, Weronika Mazur, Artur Hawajski, Natalia Jankowska, Adrianna Świerzyńska, Alicja Kapciak, Julia Górny, Katarzyna Naja

    Published 2025-02-01
    “…It is associated with many possible health consequences, ranging from acne, hirsutism, and obesity to fertility problems and even the development of endometrial cancer. Treatment is tailored to the individual, depending on various complications and needs. …”
    Get full text
    Article
  4. 444

    Validation of mortality risk scores after esophagectomy by Sabine Schiefer, Nerma Crnovrsanin, Ingmar F. Rompen, Nicolas Jorek, Mohammed Al-Saeedi, Thomas Schmidt, Henrik Nienhüser, Leila Sisic

    Published 2025-01-01
    “…Abstract Purpose Oncological esophagectomy is the mainstay in esophageal cancer treatment, but perioperative mortality remains a significant concern. …”
    Get full text
    Article
  5. 445

    Activating CD137 Signaling Promotes Sprouting Angiogenesis via Increased VEGFA Secretion and the VEGFR2/Akt/eNOS Pathway by Bo Li, Yue Zhang, Runting Yin, Wei Zhong, Rui Chen, Jinchuan Yan

    Published 2020-01-01
    “…These findings provide a basis for stabilizing intraplaque angiogenesis through VEGFR2 intervatioin, as well as cancer treatment via combination of CD137 agonists and specific VEGFR2 inhibitors.…”
    Get full text
    Article
  6. 446

    Screening for coronary artery disease among cancer survivors: rationale and design of the REDEEM-CAD study by Cheng Hwee Soh, Joel Smith, Shristy Shrestha, Mark Nolan, Joshua Wong, Nitesh Nerlekar, Thomas H. Marwick

    Published 2025-02-01
    “…Cancer survivors aged ≥ 40 years with cancer treatment ≥ 5 years prior are eligible for the study. …”
    Get full text
    Article
  7. 447

    A Novel Bacteriophage with the Potential to Inhibit <i>Fusobacterium nucleatum</i>-Induced Proliferation of Colorectal Cancer Cells by Ho Yin Pekkle Lam, Meng-Jiun Lai, Pin-Chun Wang, Wen-Jui Wu, Li-Kuang Chen, Hsiang-Wei Fan, Chun-Chieh Tseng, Shih-Yi Peng, Kai-Chih Chang

    Published 2025-01-01
    “…Conclusions: Our results demonstrated the use of <i>F. nucleatum</i> bacteriophage against CRC, laying the foundation for the future usage of bacteriophage in cancer treatment.…”
    Get full text
    Article
  8. 448

    Postoperative Outcomes of Modified Carnoy’s Solution versus 5-Fluorouracil for Chemical Cauterisation following Enucleation and Peripheral Ostectomy in Patients with Odontogenic Ke... by Nidhi Vijay Kumar Bodiwala, Nitin Bhola

    Published 2025-02-01
    “…Modified Carnoy’s Solution (MCS) is commonly used due to its effectiveness, while 5FU, an antimetabolite used in cancer treatment, presents a newer approach. Need of the study: The varying Recurrence Rate (RR) and postoperative complications associated with different treatment modalities for OKC. …”
    Get full text
    Article
  9. 449

    Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/Chemodynamic‐Induced Cancer Immunotherapy by Hangyi Wu, Xiaoyu Lu, Yuhan Hu, J. Baatarbolat, Zhihao Zhang, Yiping Liang, Youwen Zhang, Ye Liu, Huixia Lv, Xin Jin

    Published 2025-02-01
    “…Overall, ECNM can activate antitumor immunity via cuproptosis and CDT, together with TIM reversing, for cancer treatment.…”
    Get full text
    Article
  10. 450

    Multi-stage structure-based virtual screening approach combining 3D pharmacophore, docking and molecular dynamic simulation towards the identification of potential selective PARP-1... by Mahmoud A. El Hassab, Wagdy M. Eldehna, Ghaneya S. Hassan, Sahar M. Abou-Seri

    Published 2025-02-01
    “…Several enzymes and proteins have been discovered as highly attractive targets for cancer treatment. The PARP family consists of 17 members and plays a crucial role in repairing DNA damage, which enables the survival of cancer cells. …”
    Get full text
    Article
  11. 451

    Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway by Laura Giannotti, Benedetta Di Chiara Stanca, Francesco Spedicato, Daniele Vergara, Eleonora Stanca, Fabrizio Damiano, Luisa Siculella

    Published 2024-12-01
    “…Cannabinoids include both endogenous endocannabinoids and exogenous phytocannabinoids, such as cannabidiol (CBD), and have potential as therapeutic agents in cancer treatment due to their selective anticancer activities. …”
    Get full text
    Article
  12. 452

    Evaluating the Accuracy, Quality, and Readability of Online Breast Cancer Information by Elsie A. Valencia, BS, Chandler S. Cortina, MD, MS, FSSO, FACS, Adrienne N. Cobb, MD, MS, Lubna N. Chaudhary, MD, MS, Tracy Kelly, MD, Amanda L. Kong, MD, MS, FSSO, FACS

    Published 2024-09-01
    “…Conclusion:. As breast cancer treatment has become increasingly complex, improving online quality and readability while maintaining high accuracy is essential to promote health equity and empower patients to make informed decisions about their care.…”
    Get full text
    Article
  13. 453

    Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation by Tao Huang, Longqian Wei, Huafu Zhou, Jun Liu

    Published 2025-01-01
    “…Despite progress in immunotherapy for cancer treatment, its application and efficacy in ESCC remain limited. …”
    Get full text
    Article
  14. 454

    A novel ubiquitination-related gene signature for overall survival prediction in patients with liver hepatocellular carcinoma by Xiuyun Chen, SenLin Li, Lixue Cao, Shaoxian Chen, Qiuxiong Lin, Shilong Zhong

    Published 2025-01-01
    “…In conclusion, our study identified a twelve UbRGs signature that may serve as a prognostic predictor for LIHC patients and and provide valuable insights for cancer treatment.…”
    Get full text
    Article
  15. 455

    Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy by Jean-Baptiste Delmotte, Abdulkarim Tutakhail, Kahina Abdallah, Pauline Reach, Marguerite D’Ussel, Gael Deplanque, Hélène Beaussier, François Coudoré

    Published 2018-01-01
    “…Oxaliplatin is a platinum compound widely used in gastrointestinal cancer treatment but produces dose-limiting peripheral neuropathy. …”
    Get full text
    Article
  16. 456

    Qualitative analysis of patients’ feedback from a PROMs survey of cancer patients in England by Richard Wagland, Jessica Corner, Adam Glaser, Sir Mike Richards

    Published 2013-04-01
    “…This contrasted with experiences of care after primary cancer treatment where the majority were negative. Factors impacting negatively upon patient-reported outcomes included the emotional impact of cancer; poor experiences of treatment and care; comorbidities, treatment side effects, social difficulties and inadequate preparation for a wide range of sometimes long-lasting on-going physical and psychological problems. …”
    Get full text
    Article
  17. 457

    MSC-Derived Extracellular Vesicle-Delivered L-PGDS Inhibit Gastric Cancer Progression by Suppressing Cancer Cell Stemness and STAT3 Phosphorylation by Benshuai You, Can Jin, Jiaxin Zhang, Min Xu, Wenrong Xu, Zixuan Sun, Hui Qian

    Published 2022-01-01
    “…In conclusion, our results imply that MSC-derived EVs could be utilized as an effective nanovehicle to deliver L-PGDS for gastric cancer treatment, which provides a novel idea for the EV-based cancer therapy.…”
    Get full text
    Article
  18. 458

    Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy by Seyed Reza Taha, Mehdi Karimi, Bahar Mahdavi, Milad Yousefi Tehrani, Ali Bemani, Shahriar Kabirian, Javad Mohammadi, Sina Jabbari, Meysam Hushmand, Alireza Mokhtar, Mohammad Hossein Pourhanifeh

    Published 2025-01-01
    “…The targeted modulation of ncRNA-PCD interactions presents promising avenues for personalized cancer treatment, which may improve patient outcomes by enhancing therapeutic effectiveness and reducing resistance.…”
    Get full text
    Article
  19. 459

    WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis by Weiliang Jiang, Bingjie Guan, Hongcheng Sun, Yushuai Mi, Sanjun Cai, Rong Wan, Xinxiang Li, Peng Lian, Dawei Li, Senlin Zhao

    Published 2025-02-01
    “…Abstract Liver metastasis (LM) poses a significant challenge in cancer treatment, with limited available therapeutic options and poor prognosis. …”
    Get full text
    Article
  20. 460

    Training for tomorrow: Establishing a worldwide curriculum in online adaptive radiation therapy by Meegan Shepherd, Elizabeth Joyce, Bethany Williams, Siobhan Graham, Winnie Li, Jeremy Booth, Helen A. McNair

    Published 2025-03-01
    “…This commentary discusses the implementation of online adaptive radiation therapy (oART) in cancer treatment within the context of current challenges faced by radiation therapy professionals. oART enables modifications to treatment plans based on daily imaging, enhancing target accuracy while minimising harm to surrounding organs. …”
    Get full text
    Article